The drugmaker is heavily discounting its immune-disease drug Humira to protect market share this year.
Tag: ABV
WSJ News Exclusive | AbbVie Aims for New Drugs to Boost Sales as Competitors Target Humira
pharmaceutical company ABV Inc. is looking for its next hit. Now its blockbuster immune-disease therapy Humira…
A New U.S. Law Aims to Reduce Drug Prices. But First, It Might Raise Them.
Pharmaceutical companies may try to cap the price hike in future.